Literature DB >> 17056721

Angiogenesis-independent tumor growth mediated by stem-like cancer cells.

Per Ø Sakariassen1, Lars Prestegarden, Jian Wang, Kai-Ove Skaftnesmo, Rupavathana Mahesparan, Carla Molthoff, Peter Sminia, Eirik Sundlisaeter, Anjan Misra, Berit Bølge Tysnes, Martha Chekenya, Hans Peters, Gabriel Lende, Karl Henning Kalland, Anne M Øyan, Kjell Petersen, Inge Jonassen, Albert van der Kogel, Burt G Feuerstein, A Jorge A Terzis, Rolf Bjerkvig, Per Øyvind Enger.   

Abstract

In this work, highly infiltrative brain tumors with a stem-like phenotype were established by xenotransplantation of human brain tumors in immunodeficient nude rats. These tumors coopted the host vasculature and presented as an aggressive disease without signs of angiogenesis. The malignant cells expressed neural stem cell markers, showed a migratory behavior similar to normal human neural stem cells, and gave rise to tumors in vivo after regrafting. Serial passages in animals gradually transformed the tumors into an angiogenesis-dependent phenotype. This process was characterized by a reduction in stem cells markers. Gene expression profiling combined with high throughput immunoblotting analyses of the angiogenic and nonangiogenic tumors identified distinct signaling networks in the two phenotypes. Furthermore, proinvasive genes were up-regulated and angiogenesis signaling genes were down-regulated in the stem-like tumors. In contrast, proinvasive genes were down-regulated in the angiogenesis-dependent tumors derived from the stem-like tumors. The described angiogenesis-independent tumor growth and the uncoupling of invasion and angiogenesis, represented by the stem-like cancer cells and the cells derived from them, respectively, point at two completely independent mechanisms that drive tumor progression. This article underlines the need for developing therapies that specifically target the stem-like cell pools in tumors.

Entities:  

Mesh:

Year:  2006        PMID: 17056721      PMCID: PMC1618812          DOI: 10.1073/pnas.0607668103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  Multicellular tumor spheroids from human gliomas maintained in organ culture.

Authors:  R Bjerkvig; A Tønnesen; O D Laerum; E O Backlund
Journal:  J Neurosurg       Date:  1990-03       Impact factor: 5.115

2.  Growth of precultured human glioma specimens in nude rat brain.

Authors:  O Engebraaten; G O Hjortland; H Hirschberg; O Fodstad
Journal:  J Neurosurg       Date:  1999-01       Impact factor: 5.115

3.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

Authors:  J Holash; P C Maisonpierre; D Compton; P Boland; C R Alexander; D Zagzag; G D Yancopoulos; S J Wiegand
Journal:  Science       Date:  1999-06-18       Impact factor: 47.728

4.  Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: quality and analysis results of a phase I trial.

Authors:  N Shastry Akella; Donald B Twieg; Tom Mikkelsen; Fred H Hochberg; Stuart Grossman; Gretchen A Cloud; L Burt Nabors
Journal:  J Magn Reson Imaging       Date:  2004-12       Impact factor: 4.813

5.  Isolation of cancer stem cells from adult glioblastoma multiforme.

Authors:  Xiangpeng Yuan; James Curtin; Yizhi Xiong; Gentao Liu; Sebastian Waschsmann-Hogiu; Daniel L Farkas; Keith L Black; John S Yu
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

6.  Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation.

Authors:  Ole Johan Halvorsen; Anne Margrete Oyan; Trond Hellem Bø; Sue Olsen; Kari Rostad; Svein Andreas Haukaas; August Magnar Bakke; Bruz Marzolf; Krassen Dimitrov; Laila Stordrange; Biaoyang Lin; Inge Jonassen; Leroy Hood; Lars Andreas Akslen; Karl-Henning Kalland
Journal:  Int J Oncol       Date:  2005-02       Impact factor: 5.650

7.  Imaging proliferation in vivo with [F-18]FLT and positron emission tomography.

Authors:  A F Shields; J R Grierson; B M Dohmen; H J Machulla; J C Stayanoff; J M Lawhorn-Crews; J E Obradovich; O Muzik; T J Mangner
Journal:  Nat Med       Date:  1998-11       Impact factor: 53.440

8.  Secreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activation.

Authors:  Qing Shi; Shideng Bao; Jill A Maxwell; Elizabeth D Reese; Henry S Friedman; Darell D Bigner; Xiao-Fan Wang; Jeremy N Rich
Journal:  J Biol Chem       Date:  2004-10-05       Impact factor: 5.157

9.  Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro.

Authors:  O Engebraaten; R Bjerkvig; P H Pedersen; O D Laerum
Journal:  Int J Cancer       Date:  1993-01-21       Impact factor: 7.396

10.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

View more
  93 in total

Review 1.  Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.

Authors:  Robert Strauss; Petra Hamerlik; André Lieber; Jiri Bartek
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

2.  VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling.

Authors:  Lingchao Chen; Lei Han; Kailiang Zhang; Zhendong Shi; Junxia Zhang; Anling Zhang; Yongzhi Wang; Yijun Song; Yongli Li; Tao Jiang; Peiyu Pu; Chuanlu Jiang; Chunsheng Kang
Journal:  Neuro Oncol       Date:  2012-05-30       Impact factor: 12.300

3.  VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.

Authors:  D Zhao; C Pan; J Sun; C Gilbert; K Drews-Elger; D J Azzam; M Picon-Ruiz; M Kim; W Ullmer; D El-Ashry; C J Creighton; J M Slingerland
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

4.  Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.

Authors:  Susann Herzog; Matthias Alexander Fink; Kerstin Weitmann; Claudius Friedel; Stefan Hadlich; Sönke Langner; Katharina Kindermann; Tobias Holm; Andreas Böhm; Eskil Eskilsson; Hrvoje Miletic; Markus Hildner; Michael Fritsch; Silke Vogelgesang; Christoph Havemann; Christoph Alexander Ritter; Henriette Elisabeth Meyer zu Schwabedissen; Bernhard Rauch; Wolfgang Hoffmann; Heyo Klaus Kroemer; Henry Schroeder; Sandra Bien-Möller
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

5.  "The development tumor model" to study and monitor the entire progression of both primary and metastatic tumors.

Authors:  Enrico Brognaro
Journal:  Tumour Biol       Date:  2013-11-10

6.  Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

Authors:  Christine E Brown; Renate Starr; Catalina Martinez; Brenda Aguilar; Massimo D'Apuzzo; Ivan Todorov; Chu-Chih Shih; Behnam Badie; Michael Hudecek; Stanley R Riddell; Michael C Jensen
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

7.  Age-Dependent Association between Protein Expression of the Embryonic Stem Cell Marker Cripto-1 and Survival of Glioblastoma Patients.

Authors:  Berit B Tysnes; Hege A Satran; Sverre J Mork; Naira V Margaryan; Geir E Eide; Kjell Petersen; Luigi Strizzi; Mary J C Hendrix
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

Review 8.  Tumor initiating cells in malignant gliomas: biology and implications for therapy.

Authors:  Costas G Hadjipanayis; Erwin G Van Meir
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

Review 9.  Mouse models for studying angiogenesis and lymphangiogenesis in cancer.

Authors:  Lauri Eklund; Maija Bry; Kari Alitalo
Journal:  Mol Oncol       Date:  2013-03-05       Impact factor: 6.603

10.  Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.

Authors:  Peter C Huszthy; Tsanan Giroglou; Oleg Tsinkalovsky; Philipp Euskirchen; Kai Ove Skaftnesmo; Rolf Bjerkvig; Dorothee von Laer; Hrvoje Miletic
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.